Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hydrogel Urothelial Cancer Therapies
10
Mins
June 2025
Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…
Read more
5
Mins
22 Mar 2022
Ewing’s Sarcoma of the Lung as a Second Malignancy in Long-Term Survivor of Childhood Hodgkin’s Lymphoma: A Rare Case Report and Literature Review
Long-term survivors of lymphoma frequently suffer relapses, such as Ewing’s sarcoma, following radiotherapy and chemotherapy…
13
Mins
21 Mar 2022
Multidisciplinary Team Approach in Cancer Care: A Review of the Latest Advancements Featured at ESMO 2021
A collaborative approach from healthcare professionals is necessary for the management of patients with cancer to diagnose and treat…
8
Mins
7 Mar 2022
Implementation of MET Molecular Testing in the Clinic: Latest Evidence for Mesenchymal–Epithelial Transition Inhibitors in Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is a heterogeneous disease with many genomic mutations. Furthermore, comprehensive genomic…
7
Mins
24 Feb 2022
Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer
Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
11
Mins
18 Feb 2022
New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders
CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…
3
Mins
8 Feb 2022
Interview: Carlos Caldas
Carlos Caldas | Clinician Scientist and Senior Group Leader, Cancer Research UK Cambridge Institute; Chair of Medicine…
14
Mins
3 Feb 2022
Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine
This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…
10
Mins
21 Jan 2022
Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer
Lung cancer has a devastating global impact, claiming almost 2 million lives in 2020.1 Despite advances in treatment, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.
Loading posts...
« Previous
1
…
7
8
9
10
11
…
29
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View